SIMILAR PATTERNS OF AMINO ACIDS FOR 2B7Z_B_MK1B200_2

List of similar pattern of amino acids derived from ASSAM search

Hit pattern: 3D amino acid arrangements similar to known drug binding site

Query pattern: Residues from known binding site for annotated drug that match the hit pattern


(Click link on the last column to view superposed patterns of amino acids in NGL viewer)
(Note that only 3-12 residue patterns can be used for ASSAM searches)
Filter list by:
Hit Macromolecule/
Organism
Pfam Res. Interface HETATM RMSD Dali Z-score Seq. Identity (%) View Dock
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1bdm MALATE DEHYDROGENASE

(Thermus
thermophilus)
PF00056
(Ldh_1_N)
PF02866
(Ldh_1_C)
5 ALA A 139
ILE A 107
GLY A 105
PRO A 131
VAL A 127
None
NAX  A 334 ( 4.0A)
None
None
None
1.08A 2b7zB-1bdmA:
undetectable
2b7zB-1bdmA:
14.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1gvl KALLIKREIN 6

(Homo sapiens)
PF00089
(Trypsin)
5 GLY A  44
ALA A  31
ILE A 118
ILE A  47
VAL A  66
None
0.84A 2b7zB-1gvlA:
undetectable
2b7zB-1gvlA:
18.72
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1gz5 ALPHA-TREHALOSE-PHOS
PHATE SYNTHASE


(Escherichia
coli)
PF00982
(Glyco_transf_20)
5 GLY A 389
ALA A 390
ILE A 434
GLY A 226
ILE A 225
None
None
None
None
IMD  A 902 ( 4.3A)
0.72A 2b7zB-1gz5A:
undetectable
2b7zB-1gz5A:
15.81
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1hvc HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
6 ALA A  28
ASP A  30
ILE A  47
GLY A  49
ILE A  50
PRO A  81
A79  A 800 (-3.2A)
A79  A 800 ( 4.7A)
A79  A 800 ( 3.4A)
A79  A 800 (-3.4A)
A79  A 800 ( 4.0A)
A79  A 800 ( 3.4A)
0.53A 2b7zB-1hvcA:
13.3
2b7zB-1hvcA:
89.90
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1hvc HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
6 ASP A  25
ALA A  28
ASP A  30
ILE A  47
GLY A  49
ILE A  50
A79  A 800 (-2.7A)
A79  A 800 (-3.1A)
A79  A 800 ( 4.9A)
A79  A 800 ( 3.2A)
A79  A 800 ( 3.7A)
A79  A 800 (-3.8A)
0.54A 2b7zB-1hvcA:
13.3
2b7zB-1hvcA:
89.90
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1hvc HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
6 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
ALA A  22
A79  A 800 (-2.7A)
A79  A 800 (-3.0A)
A79  A 800 (-3.1A)
A79  A 800 (-2.8A)
A79  A 800 ( 4.9A)
None
1.47A 2b7zB-1hvcA:
13.3
2b7zB-1hvcA:
89.90
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1hvc HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
6 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
ALA A  22
A79  A 800 (-2.8A)
A79  A 800 (-3.0A)
A79  A 800 (-3.2A)
A79  A 800 (-2.7A)
A79  A 800 ( 4.7A)
None
1.40A 2b7zB-1hvcA:
13.3
2b7zB-1hvcA:
89.90
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1hvc HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
7 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
ILE A  47
GLY A  49
A79  A 800 (-2.7A)
A79  A 800 (-3.0A)
A79  A 800 (-3.1A)
A79  A 800 (-2.8A)
A79  A 800 ( 4.9A)
A79  A 800 ( 3.2A)
A79  A 800 ( 3.7A)
0.35A 2b7zB-1hvcA:
13.3
2b7zB-1hvcA:
89.90
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1hvc HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
8 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
ILE A  47
GLY A  49
PRO A  81
A79  A 800 (-2.8A)
A79  A 800 (-3.0A)
A79  A 800 (-3.2A)
A79  A 800 (-2.7A)
A79  A 800 ( 4.7A)
A79  A 800 ( 3.4A)
A79  A 800 (-3.4A)
A79  A 800 ( 3.4A)
0.36A 2b7zB-1hvcA:
13.3
2b7zB-1hvcA:
89.90
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1hvc HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
7 ASP A  25
GLY A  27
ALA A  28
ASP A  30
ILE A  47
GLY A  49
PRO A  81
A79  A 800 (-2.7A)
A79  A 800 (-3.0A)
A79  A 800 (-3.1A)
A79  A 800 ( 4.9A)
A79  A 800 ( 3.2A)
A79  A 800 ( 3.7A)
A79  A 800 ( 3.9A)
0.50A 2b7zB-1hvcA:
13.3
2b7zB-1hvcA:
89.90
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1hyl HYPODERMA LINEATUM
COLLAGENASE


(Hypoderma
lineatum)
PF00089
(Trypsin)
5 GLY A  44
ALA A  31
ILE A 118
ILE A  47
VAL A  66
None
0.83A 2b7zB-1hylA:
undetectable
2b7zB-1hylA:
18.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1n7k DEOXYRIBOSE-PHOSPHAT
E ALDOLASE


(Aeropyrum
pernix)
PF01791
(DeoC)
5 ARG A 184
GLY A 215
ALA A 216
ILE A 165
ALA A 143
None
1.08A 2b7zB-1n7kA:
undetectable
2b7zB-1n7kA:
18.26
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1obh LEUCYL-TRNA
SYNTHETASE


(Thermus
thermophilus)
PF00133
(tRNA-synt_1)
PF08264
(Anticodon_1)
PF13603
(tRNA-synt_1_2)
PF14795
(Leucyl-specific)
5 GLY A 304
ALA A 325
ASP A 326
ALA A 339
VAL A 260
None
1.01A 2b7zB-1obhA:
2.2
2b7zB-1obhA:
7.83
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1q9p HIV-1 PROTEASE

(Homo sapiens)
PF00077
(RVP)
5 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
None
0.38A 2b7zB-1q9pA:
9.9
2b7zB-1q9pA:
86.32
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1siv SIV PROTEASE

(Simian
immunodeficiency
virus)
PF00077
(RVP)
8 ARG A   8
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
GLY A  49
PRO A  81
None
0.47A 2b7zB-1sivA:
18.9
2b7zB-1sivA:
51.52
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1siv SIV PROTEASE

(Simian
immunodeficiency
virus)
PF00077
(RVP)
5 ARG A   8
ASP A  30
GLY A  49
ILE A  50
PRO A  81
None
0.74A 2b7zB-1sivA:
18.9
2b7zB-1sivA:
51.52
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1sqj OLIGOXYLOGLUCAN
REDUCING-END-SPECIFI
C CELLOBIOHYDROLASE


(Geotrichum sp.
M128)
PF15899
(BNR_6)
5 ARG A 141
ASP A  89
ASP A  60
ILE A  56
ILE A  36
None
1.05A 2b7zB-1sqjA:
undetectable
2b7zB-1sqjA:
7.86
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1u11 PURE
(N5-CARBOXYAMINOIMID
AZOLE RIBONUCLEOTIDE
MUTASE)


(Acetobacter
aceti)
PF00731
(AIRC)
5 GLY A  85
ALA A  84
ASP A  33
GLY A 136
ILE A 135
CIT  A1001 (-4.3A)
CIT  A1001 (-3.8A)
CIT  A1001 (-2.9A)
None
None
1.04A 2b7zB-1u11A:
undetectable
2b7zB-1u11A:
20.42
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1x44 MYOSIN-BINDING
PROTEIN C, SLOW-TYPE


(Homo sapiens)
PF07679
(I-set)
5 ALA A  36
ASP A  35
ASP A  34
ILE A  57
VAL A  31
None
0.99A 2b7zB-1x44A:
undetectable
2b7zB-1x44A:
25.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2aeu HYPOTHETICAL PROTEIN
MJ0158


(Methanocaldococcus
jannaschii)
PF03841
(SelA)
5 ASP A 179
GLY A 182
ALA A 183
ALA A 199
VAL A 202
None
0.91A 2b7zB-2aeuA:
undetectable
2b7zB-2aeuA:
12.90
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2dnc PYRUVATE
DEHYDROGENASE
PROTEIN X COMPONENT


(Homo sapiens)
PF00364
(Biotin_lipoyl)
5 ALA A  55
ASP A  57
ILE A   8
ILE A  79
VAL A  35
None
0.75A 2b7zB-2dncA:
undetectable
2b7zB-2dncA:
20.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2e2n HEXOKINASE

(Sulfurisphaera
tokodaii)
PF01869
(BcrAD_BadFG)
5 GLY A  29
ALA A  16
ILE A  48
ALA A  60
VAL A   5
None
1.04A 2b7zB-2e2nA:
undetectable
2b7zB-2e2nA:
16.60
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE


(Equine
infectious
anemia virus)
PF00077
(RVP)
8 ARG A   8
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ILE A  53
GLY A  55
PRO A  86
LP1  A 201 (-3.5A)
LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
LP1  A 201 (-4.6A)
LP1  A 201 (-3.4A)
LP1  A 201 (-3.9A)
0.54A 2b7zB-2fmbA:
15.1
2b7zB-2fmbA:
27.88
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2inv INSULIN
FRUCTOTRANSFERASE


(Bacillus sp.
snu-7)
no annotation 5 ASP A  73
GLY A  75
ALA A  76
ASP A  80
VAL A  68
None
1.08A 2b7zB-2invA:
undetectable
2b7zB-2invA:
14.99
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2olg PRO-PHENOLOXIDASE
ACTIVATING ENZYME-I


(Holotrichia
diomphalia)
PF00089
(Trypsin)
5 GLY A 142
ALA A 125
ILE A 236
ILE A 145
VAL A 171
None
0.85A 2b7zB-2olgA:
undetectable
2b7zB-2olgA:
17.21
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2rkf PROTEASE RETROPEPSIN

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
10 ARG A   8
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
GLY A  49
ILE A  50
PRO A  81
ALA A  82
AB1  A 501 ( 4.7A)
AB1  A 501 (-2.4A)
AB1  A 501 (-3.9A)
AB1  A 501 (-3.5A)
AB1  A 501 ( 3.3A)
AB1  A 501 (-3.8A)
AB1  A 501 (-3.5A)
AB1  A 501 (-3.8A)
AB1  A 501 (-4.2A)
AB1  A 501 (-3.6A)
0.44A 2b7zB-2rkfA:
20.7
2b7zB-2rkfA:
85.86
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2rkf PROTEASE RETROPEPSIN

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
6 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
ALA A  22
AB1  A 501 (-2.4A)
AB1  A 501 (-3.9A)
AB1  A 501 (-3.5A)
AB1  A 501 ( 3.3A)
AB1  A 501 (-3.8A)
None
1.32A 2b7zB-2rkfA:
20.7
2b7zB-2rkfA:
85.86
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2rsp RSV PROTEASE

(Rous sarcoma
virus)
PF00077
(RVP)
5 ARG A  10
ASP A  37
GLY A  39
ALA A  40
ASP A  41
None
0.76A 2b7zB-2rspA:
12.8
2b7zB-2rspA:
32.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2vn8 RETICULON-4-INTERACT
ING PROTEIN 1


(Homo sapiens)
PF08240
(ADH_N)
PF13602
(ADH_zinc_N_2)
5 GLY A 248
ALA A 249
ASP A 250
ASP A 251
ALA A 240
None
1.05A 2b7zB-2vn8A:
undetectable
2b7zB-2vn8A:
19.85
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2w3y VIRULENCE FACTOR

(Pectobacterium
carotovorum)
no annotation 5 ASP A 244
ILE A 230
GLY A  63
ILE A  65
VAL A 243
None
0.91A 2b7zB-2w3yA:
undetectable
2b7zB-2w3yA:
17.18
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2z1u HYDROGENASE
EXPRESSION/FORMATION
PROTEIN HYPE


(Desulfovibrio
vulgaris)
PF00586
(AIRS)
PF02769
(AIRS_C)
5 GLY A 233
ALA A 232
ILE A 275
ALA A 225
VAL A 317
None
1.06A 2b7zB-2z1uA:
undetectable
2b7zB-2z1uA:
14.49
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3c6m SPERMINE SYNTHASE

(Homo sapiens)
PF01564
(Spermine_synth)
PF17284
(Spermine_synt_N)
5 ARG A 268
ILE A 221
GLY A 198
ILE A 196
VAL A 259
None
MTA  A 401 (-3.8A)
MTA  A 401 (-3.3A)
None
None
1.04A 2b7zB-3c6mA:
undetectable
2b7zB-3c6mA:
15.84
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3emy TRICHODERMA REESEI
ASPARTIC PROTEASE


(Trichoderma
reesei)
PF00026
(Asp)
5 GLY A 298
ASP A 224
ILE A 207
GLY A 212
ILE A 213
None
0.88A 2b7zB-3emyA:
6.6
2b7zB-3emyA:
16.43
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3fv3 SAPP1P-SECRETED
ASPARTIC PROTEASE 1


(Candida
parapsilosis)
PF00026
(Asp)
5 ASP A 220
GLY A 222
GLY A 119
ILE A 120
ALA A 196
None
0.95A 2b7zB-3fv3A:
7.7
2b7zB-3fv3A:
12.98
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3gi8 UNCHARACTERIZED
PROTEIN MJ0609


(Methanocaldococcus
jannaschii)
PF13520
(AA_permease_2)
5 GLY C 279
ALA C 280
GLY C  23
ILE C  22
ALA C 259
None
1.03A 2b7zB-3gi8C:
undetectable
2b7zB-3gi8C:
12.50
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3gt7 SENSOR PROTEIN

(Syntrophus
aciditrophicus)
PF00072
(Response_reg)
5 ARG A 102
GLY A 107
ALA A 108
ASP A 109
ILE A  59
None
0.98A 2b7zB-3gt7A:
undetectable
2b7zB-3gt7A:
22.30
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3kf3 INVERTASE

(Schwanniomyces
occidentalis)
PF00251
(Glyco_hydro_32N)
PF08244
(Glyco_hydro_32C)
5 ASP A 287
GLY A 289
ASP A 291
ILE A 485
PRO A 355
None
None
None
None
NAG  A5001 ( 4.9A)
0.93A 2b7zB-3kf3A:
undetectable
2b7zB-3kf3A:
12.22
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3lez BETA-LACTAMASE

(Oceanobacillus
iheyensis)
PF13354
(Beta-lactamase2)
5 ALA A  64
GLY A 260
ILE A 259
ALA A 294
VAL A 298
None
0.97A 2b7zB-3lezA:
undetectable
2b7zB-3lezA:
19.72
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3lez BETA-LACTAMASE

(Oceanobacillus
iheyensis)
PF13354
(Beta-lactamase2)
5 ALA A  64
ILE A 262
GLY A 260
ILE A 259
ALA A 294
None
0.81A 2b7zB-3lezA:
undetectable
2b7zB-3lezA:
19.72
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3lp6 PHOSPHORIBOSYLAMINOI
MIDAZOLE CARBOXYLASE
CATALYTIC SUBUNIT


(Mycobacterium
tuberculosis)
PF00731
(AIRC)
5 GLY A  71
ALA A  70
ASP A  19
GLY A 122
ILE A 121
FMT  A 175 (-4.1A)
FMT  A 175 ( 4.3A)
FMT  A 175 (-3.5A)
None
None
0.97A 2b7zB-3lp6A:
undetectable
2b7zB-3lp6A:
18.29
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3mws HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
5 ALA A  28
ASP A  29
ASP A  30
GLY A  48
PRO A  81
None
0.88A 2b7zB-3mwsA:
19.8
2b7zB-3mwsA:
74.75
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3mws HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
8 ARG A   8
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
ILE A  47
PRO A  81
None
0.55A 2b7zB-3mwsA:
19.8
2b7zB-3mwsA:
74.75
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3mws HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
9 ARG A   8
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ILE A  47
GLY A  49
ILE A  50
PRO A  81
None
0.53A 2b7zB-3mwsA:
19.8
2b7zB-3mwsA:
74.75
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3mws HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
6 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
ALA A  22
None
1.31A 2b7zB-3mwsA:
19.8
2b7zB-3mwsA:
74.75
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3opq PHOSPHORIBOSYLAMINOI
MIDAZOLE
CARBOXYLASE,CATALYTI
C SUBUNIT


(Francisella
tularensis)
PF00731
(AIRC)
5 GLY A  66
ALA A  65
ASP A  14
GLY A 117
ILE A 116
PO4  A 164 (-3.7A)
PO4  A 164 (-3.3A)
PO4  A 164 (-2.8A)
FMT  A 166 (-3.3A)
None
1.00A 2b7zB-3opqA:
undetectable
2b7zB-3opqA:
21.25
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3q9t CHOLINE
DEHYDROGENASE AND
RELATED
FLAVOPROTEINS


(Aspergillus
oryzae)
PF00732
(GMC_oxred_N)
PF05199
(GMC_oxred_C)
5 GLY A 280
ASP A 297
GLY A 537
ALA A 518
VAL A 301
None
1.06A 2b7zB-3q9tA:
undetectable
2b7zB-3q9tA:
11.56
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3qlj SHORT CHAIN
DEHYDROGENASE


(Mycobacterium
avium)
PF00106
(adh_short)
5 GLY A 102
ALA A 101
ILE A 178
ALA A 130
VAL A  74
CL  A 302 (-3.6A)
None
None
None
None
0.92A 2b7zB-3qljA:
undetectable
2b7zB-3qljA:
14.60
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3sn0 PUTATIVE
L-ALANINE-DL-GLUTAMA
TE EPIMERASE


(Paraburkholderia
xenovorans)
PF02746
(MR_MLE_N)
PF13378
(MR_MLE_C)
5 ARG A 273
GLY A  80
ASP A 290
GLY A  87
ILE A  86
None
0.83A 2b7zB-3sn0A:
undetectable
2b7zB-3sn0A:
12.81
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3t3c HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
8 ALA A  28
ASP A  29
ASP A  30
ILE A  47
GLY A  49
PRO A  81
ALA A  82
VAL A  84
017  A 201 (-3.5A)
017  A 201 (-3.5A)
017  A 201 (-4.2A)
None
017  A 201 (-4.0A)
None
SO4  A 101 (-3.5A)
None
0.62A 2b7zB-3t3cA:
18.9
2b7zB-3t3cA:
77.78
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3t3c HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
5 ARG A   8
ASP A  29
ILE A  47
GLY A  49
ILE A  50
SO4  A 101 (-3.8A)
017  A 201 (-3.5A)
None
017  A 201 (-4.0A)
017  A 201 (-3.3A)
0.71A 2b7zB-3t3cA:
18.9
2b7zB-3t3cA:
77.78
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3t3c HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
10 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
ILE A  47
GLY A  49
ILE A  50
ALA A  82
VAL A  84
017  A 201 (-2.6A)
017  A 201 (-3.4A)
017  A 201 (-3.5A)
017  A 201 (-3.5A)
017  A 201 (-4.2A)
None
017  A 201 (-4.0A)
017  A 201 (-3.3A)
SO4  A 101 (-3.5A)
None
0.49A 2b7zB-3t3cA:
18.9
2b7zB-3t3cA:
77.78
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3trh PHOSPHORIBOSYLAMINOI
MIDAZOLE CARBOXYLASE
CARBOXYLTRANSFERASE
SUBUNIT


(Coxiella
burnetii)
PF00731
(AIRC)
5 GLY A  67
ALA A  66
ASP A  15
GLY A 118
ILE A 117
None
1.04A 2b7zB-3trhA:
undetectable
2b7zB-3trhA:
20.81
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3ttp HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
8 ARG A   8
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
ILE A  50
PRO A  81
017  A 201 ( 4.8A)
017  A 201 (-2.6A)
017  A 201 (-3.6A)
017  A 201 (-3.4A)
017  A 201 (-3.3A)
017  A 201 (-4.6A)
017  A 201 (-3.3A)
017  A 201 (-4.1A)
0.46A 2b7zB-3ttpA:
20.3
2b7zB-3ttpA:
81.82
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3ttp HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
8 ARG A   8
ASP A  25
GLY A  27
ALA A  28
ASP A  29
GLY A  49
ILE A  50
PRO A  81
017  A 201 ( 4.8A)
017  A 201 (-2.6A)
017  A 201 (-3.6A)
017  A 201 (-3.4A)
017  A 201 (-3.3A)
017  A 201 (-3.0A)
017  A 201 (-3.3A)
017  A 201 (-4.1A)
0.41A 2b7zB-3ttpA:
20.3
2b7zB-3ttpA:
81.82
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3ttp HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
6 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
ALA A  22
017  A 201 (-2.6A)
017  A 201 (-3.6A)
017  A 201 (-3.4A)
017  A 201 (-3.3A)
017  A 201 (-4.6A)
None
1.32A 2b7zB-3ttpA:
20.3
2b7zB-3ttpA:
81.82
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3u7s POL POLYPROTEIN

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
11 ARG A   8
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
ILE A  47
GLY A  49
ILE A  50
PRO A  81
VAL A  84
None
017  A 202 ( 2.5A)
017  A 201 ( 3.5A)
017  A 201 (-3.4A)
017  A 201 (-3.2A)
017  A 201 ( 4.0A)
017  A 202 (-3.6A)
017  A 202 (-2.9A)
017  A 201 ( 3.5A)
017  A 202 (-4.0A)
None
0.55A 2b7zB-3u7sA:
20.2
2b7zB-3u7sA:
83.84
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3uhl PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
5 GLY A  27
ALA A  28
ASP A  29
PRO A  81
VAL A  84
None
0.55A 2b7zB-3uhlA:
16.5
2b7zB-3uhlA:
81.82
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3w2i NADH-CYTOCHROME B5
REDUCTASE 3


(Sus scrofa)
PF00175
(NAD_binding_1)
PF00970
(FAD_binding_6)
5 ASP A  72
ASP A  73
GLY A  43
ILE A   5
PRO A  36
None
0.99A 2b7zB-3w2iA:
undetectable
2b7zB-3w2iA:
17.41
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3wuf ENDO-1,4-BETA-XYLANA
SE A


(Streptomyces
sp.)
PF00331
(Glyco_hydro_10)
5 ASP A 291
GLY A 247
ALA A 246
PRO A 341
ALA A 342
None
1.06A 2b7zB-3wufA:
undetectable
2b7zB-3wufA:
14.87
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4ad8 DNA REPAIR PROTEIN
RECN


(Deinococcus
radiodurans)
PF02463
(SMC_N)
5 ASP A 474
ASP A 471
ILE A  70
GLY A  66
ALA A 508
None
0.82A 2b7zB-4ad8A:
undetectable
2b7zB-4ad8A:
9.86
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4c75 BETA-LACTAMASE

(synthetic
construct)
PF13354
(Beta-lactamase2)
5 ALA A  48
ILE A 250
ILE A 247
ALA A 282
VAL A 286
None
0.98A 2b7zB-4c75A:
undetectable
2b7zB-4c75A:
15.87
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4emi TODA

(Pseudomonas
putida)
PF07992
(Pyr_redox_2)
PF14759
(Reductase_C)
5 ARG A 226
ILE A 235
ILE A 171
ALA A 222
VAL A 220
None
0.98A 2b7zB-4emiA:
undetectable
2b7zB-4emiA:
14.41
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4g1u HEMIN TRANSPORT
SYSTEM PERMEASE
PROTEIN HMUU


(Yersinia pestis)
PF01032
(FecCD)
5 GLY A 126
ALA A  96
GLY A 101
ILE A 103
VAL A 251
None
1.03A 2b7zB-4g1uA:
undetectable
2b7zB-4g1uA:
14.83
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4g5e 2,4,6-TRICHLOROPHENO
L 4-MONOOXYGENASE


(Cupriavidus
pinatubonensis)
PF03241
(HpaB)
PF11794
(HpaB_N)
5 GLY A 126
ALA A 127
ILE A 183
ILE A 216
VAL A 131
None
0.85A 2b7zB-4g5eA:
undetectable
2b7zB-4g5eA:
14.35
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4grd PHOSPHORIBOSYLAMINOI
MIDAZOLE CARBOXYLASE
CATALYTIC SUBUNIT


(Burkholderia
cenocepacia)
PF00731
(AIRC)
5 GLY A  77
ALA A  76
ASP A  25
GLY A 128
ILE A 127
None
0.99A 2b7zB-4grdA:
undetectable
2b7zB-4grdA:
18.13
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4hdj OUTER MEMBRANE
PROTEIN ASSEMBLY
FACTOR BAMB


(Pseudomonas
aeruginosa)
PF13360
(PQQ_2)
5 ASP A 207
GLY A 160
ILE A 159
PRO A 187
ALA A 196
None
0.69A 2b7zB-4hdjA:
undetectable
2b7zB-4hdjA:
14.33
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4ida RIPENING-INDUCED
PROTEIN


(Fragaria vesca)
PF08240
(ADH_N)
PF13602
(ADH_zinc_N_2)
5 GLY A 208
ALA A 209
ASP A 210
ILE A 179
ALA A 196
None
None
None
None
SO4  A 402 (-3.3A)
0.94A 2b7zB-4idaA:
undetectable
2b7zB-4idaA:
16.83
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4j0k TANNASE

(Lactobacillus
plantarum)
no annotation 5 GLY A 416
ASP A 421
ILE A 206
ILE A 413
ALA A 425
None
EGR  A 501 (-3.5A)
EGR  A 501 (-4.0A)
None
None
1.04A 2b7zB-4j0kA:
undetectable
2b7zB-4j0kA:
13.70
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4jyj ENOYL-COA
HYDRATASE/ISOMERASE


(Novosphingobium
aromaticivorans)
PF00378
(ECH_1)
5 GLY A 107
ALA A 129
ASP A 168
ILE A 167
VAL A 125
None
0.99A 2b7zB-4jyjA:
undetectable
2b7zB-4jyjA:
18.62
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4jyj ENOYL-COA
HYDRATASE/ISOMERASE


(Novosphingobium
aromaticivorans)
PF00378
(ECH_1)
5 GLY A 107
ALA A 129
ILE A 167
ILE A 110
ALA A 117
None
0.87A 2b7zB-4jyjA:
undetectable
2b7zB-4jyjA:
18.62
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4k3w ENOYL-COA
HYDRATASE/ISOMERASE


(Marinobacter
hydrocarbonoclasticus)
PF00378
(ECH_1)
5 GLY A 117
ALA A 139
ASP A 179
ILE A 178
GLY A 142
None
1.03A 2b7zB-4k3wA:
undetectable
2b7zB-4k3wA:
21.25
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4k48 LEUCINE--TRNA LIGASE

(Streptococcus
pneumoniae)
PF13603
(tRNA-synt_1_2)
5 GLY A 304
ALA A 325
ASP A 326
ALA A 339
VAL A 260
None
1.00A 2b7zB-4k48A:
2.4
2b7zB-4k48A:
19.49
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4m98 PILIN GLYCOSYLATION
PROTEIN


(Neisseria
gonorrhoeae)
PF00132
(Hexapep)
5 GLY A 206
ALA A 264
ILE A 261
ALA A 218
VAL A 214
None
0.88A 2b7zB-4m98A:
undetectable
2b7zB-4m98A:
19.52
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4m9a ACYL-COA
DEHYDROGENASE


(Burkholderia
thailandensis)
PF00441
(Acyl-CoA_dh_1)
PF02770
(Acyl-CoA_dh_M)
PF02771
(Acyl-CoA_dh_N)
5 GLY A 152
GLY A 192
ILE A 194
ALA A 166
VAL A 168
None
0.93A 2b7zB-4m9aA:
undetectable
2b7zB-4m9aA:
14.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4n5f PUTATIVE ACYL-COA
DEHYDROGENASE


(Burkholderia
cenocepacia)
PF00441
(Acyl-CoA_dh_1)
PF02770
(Acyl-CoA_dh_M)
PF02771
(Acyl-CoA_dh_N)
5 GLY A 152
GLY A 192
ILE A 194
ALA A 166
VAL A 168
None
1.00A 2b7zB-4n5fA:
undetectable
2b7zB-4n5fA:
15.02
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4njv PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
6 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
ALA A  22
RIT  A 500 (-2.4A)
RIT  A 500 (-3.9A)
RIT  A 500 (-3.6A)
RIT  A 500 (-3.2A)
RIT  A 500 (-4.8A)
None
1.35A 2b7zB-4njvA:
20.1
2b7zB-4njvA:
84.85
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4njv PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
6 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
PRO A  81
RIT  A 500 (-2.4A)
RIT  A 500 (-3.9A)
RIT  A 500 (-3.6A)
RIT  A 500 (-3.2A)
RIT  A 500 (-4.8A)
RIT  A 500 (-3.9A)
0.48A 2b7zB-4njvA:
20.1
2b7zB-4njvA:
84.85
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4njv PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
7 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ILE A  47
GLY A  49
PRO A  81
RIT  A 500 (-2.4A)
RIT  A 500 (-3.9A)
RIT  A 500 (-3.6A)
RIT  A 500 (-3.2A)
RIT  A 500 ( 4.5A)
RIT  A 500 (-3.4A)
RIT  A 500 (-3.9A)
0.38A 2b7zB-4njvA:
20.1
2b7zB-4njvA:
84.85
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4njv PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
7 ASP A  25
GLY A  27
ALA A  28
ILE A  47
GLY A  49
ILE A  50
PRO A  81
RIT  A 500 (-2.4A)
RIT  A 500 (-3.9A)
RIT  A 500 (-3.6A)
RIT  A 500 ( 4.5A)
RIT  A 500 (-3.4A)
RIT  A 500 (-4.3A)
RIT  A 500 (-3.9A)
0.45A 2b7zB-4njvA:
20.1
2b7zB-4njvA:
84.85
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4q98 MAJOR FIMBRIAL
SUBUNIT PROTEIN


(Porphyromonas
gingivalis)
PF06321
(P_gingi_FimA)
PF15495
(Fimbrillin_C)
5 GLY A 261
ALA A 260
GLY A 181
PRO A 198
ALA A 201
None
0.80A 2b7zB-4q98A:
undetectable
2b7zB-4q98A:
15.90
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4qpb LYSOSTAPHIN

(Staphylococcus
simulans)
PF01551
(Peptidase_M23)
5 GLY A 344
ALA A 294
ILE A 314
GLY A 348
VAL A 341
None
0.95A 2b7zB-4qpbA:
undetectable
2b7zB-4qpbA:
24.37
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4qsl PYRUVATE CARBOXYLASE

(Listeria
monocytogenes)
no annotation 5 GLY H  77
ALA H  78
ASP H  79
ILE H  28
ALA H  32
None
0.88A 2b7zB-4qslH:
undetectable
2b7zB-4qslH:
6.98
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4ra7 PEPTIDOGLYCAN
GLYCOSYLTRANSFERASE


(Atopobium
parvulum)
PF00905
(Transpeptidase)
5 GLY A 933
ALA A 934
ILE A 887
GLY A 907
ILE A 906
None
0.77A 2b7zB-4ra7A:
undetectable
2b7zB-4ra7A:
12.67
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4rk9 CARBOHYDRATE ABC
TRANSPORTER
SUBSTRATE-BINDING
PROTEIN MSME


(Bacillus
licheniformis)
PF01547
(SBP_bac_1)
5 ILE A 303
GLY A 143
ILE A 144
PRO A 300
ALA A 293
None
1.02A 2b7zB-4rk9A:
undetectable
2b7zB-4rk9A:
20.69
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4wzz PUTATIVE SUGAR ABC
TRANSPORTER,
SUBSTRATE-BINDING
PROTEIN


(Lachnoclostridium
phytofermentans)
PF13407
(Peripla_BP_4)
5 ASP A 342
GLY A 344
ALA A 340
ILE A 348
ALA A 191
EDO  A 402 ( 4.2A)
None
None
None
EDO  A 402 ( 3.6A)
0.98A 2b7zB-4wzzA:
undetectable
2b7zB-4wzzA:
14.57
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4ydf HTLV-1 PROTEASE

(Primate
T-lymphotropic
virus 1)
PF00077
(RVP)
6 ARG A  10
ASP A  32
GLY A  34
ALA A  35
ASP A  36
GLY A  58
None
4B1  A 201 (-2.9A)
4B1  A 201 ( 4.6A)
4B1  A 201 (-3.6A)
4B1  A 201 (-4.4A)
4B1  A 201 (-3.4A)
0.54A 2b7zB-4ydfA:
12.6
2b7zB-4ydfA:
28.70
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5b18 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
5 ARG A   8
GLY A  27
ALA A  28
ASP A  29
ASP A  30
None
0.44A 2b7zB-5b18A:
18.2
2b7zB-5b18A:
79.80
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5b18 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
5 GLY A  27
ALA A  28
ASP A  29
ASP A  30
GLY A  49
None
0.67A 2b7zB-5b18A:
18.2
2b7zB-5b18A:
79.80
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5bsw 4-COUMARATE--COA
LIGASE 2


(Nicotiana
tabacum)
PF00501
(AMP-binding)
PF13193
(AMP-binding_C)
5 GLY A 101
ALA A 102
ASP A  78
ILE A 173
ALA A  93
None
1.06A 2b7zB-5bswA:
undetectable
2b7zB-5bswA:
11.18
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5evj ARSENITE
METHYLTRANSFERASE


(Chlamydomonas
reinhardtii)
PF13847
(Methyltransf_31)
5 GLY A 223
ALA A 224
GLY A 218
ALA A 264
VAL A 202
None
0.83A 2b7zB-5evjA:
undetectable
2b7zB-5evjA:
14.51
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5g4x SH3 AND MULTIPLE
ANKYRIN REPEAT
DOMAINS PROTEIN 3


(Rattus
norvegicus)
PF12796
(Ank_2)
PF16511
(FERM_f0)
5 GLY A 206
ALA A 207
ASP A 177
ALA A 190
VAL A 187
None
None
EDO  A1357 (-2.8A)
None
None
1.03A 2b7zB-5g4xA:
undetectable
2b7zB-5g4xA:
14.42
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5jho ELECTRONEUTRAL
SODIUM BICARBONATE
EXCHANGER 1


(Homo sapiens)
PF07565
(Band_3_cyto)
5 GLY A 253
ASP A  68
GLY A 304
ILE A 303
ALA A 264
None
0.97A 2b7zB-5jhoA:
undetectable
2b7zB-5jhoA:
16.33
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5t2z PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
7 ARG A   8
ASP A  25
GLY A  27
ALA A  28
GLY A  49
ILE A  50
PRO A  81
None
0.54A 2b7zB-5t2zA:
20.9
2b7zB-5t2zA:
82.83
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5t2z PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
6 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
ALA A  22
None
1.31A 2b7zB-5t2zA:
20.9
2b7zB-5t2zA:
82.83
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5t2z PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
9 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
ILE A  47
GLY A  49
ILE A  50
PRO A  81
None
0.49A 2b7zB-5t2zA:
20.9
2b7zB-5t2zA:
82.83
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5tfq BETA-LACTAMASE

(Bacteroides
cellulosilyticus)
PF13354
(Beta-lactamase2)
5 GLY A 234
ALA A 233
ASP A 232
ILE A 109
VAL A 167
None
0.81A 2b7zB-5tfqA:
undetectable
2b7zB-5tfqA:
15.16
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5w1a MYOSIN HEAVY CHAIN,
MUSCLE


(Drosophila
melanogaster)
no annotation 5 ALA A 260
ASP A 261
GLY A 457
ILE A 456
VAL A 219
None
0.97A 2b7zB-5w1aA:
undetectable
2b7zB-5w1aA:
19.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6fiv RETROPEPSIN

(Feline
immunodeficiency
virus)
PF00077
(RVP)
6 ARG A  13
ASP A  30
GLY A  32
ALA A  33
ASP A  34
GLY A  58
None
3TL  A 201 (-3.5A)
3TL  A 201 (-3.4A)
3TL  A 201 (-4.0A)
3TL  A 201 (-3.9A)
3TL  A 201 (-3.4A)
0.41A 2b7zB-6fivA:
15.8
2b7zB-6fivA:
27.97
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6upj HIV-2 PROTEASE

(Human
immunodeficiency
virus 2)
PF00077
(RVP)
5 ARG A   8
ASP A  25
GLY A  49
ILE A  50
PRO A  81
None
NIU  A 100 (-2.8A)
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
None
0.70A 2b7zB-6upjA:
18.5
2b7zB-6upjA:
50.51
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6upj HIV-2 PROTEASE

(Human
immunodeficiency
virus 2)
PF00077
(RVP)
8 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
GLY A  49
ILE A  50
PRO A  81
NIU  A 100 (-2.8A)
NIU  A 100 (-4.5A)
NIU  A 100 (-3.6A)
None
None
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
None
0.63A 2b7zB-6upjA:
18.5
2b7zB-6upjA:
50.51